• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

  • Twitter
  • YouTube
NASBS

NASBS

North American Skull Base Society

  • Home
  • About
    • Mission Statement
    • Bylaws
    • NASBS Board of Directors
    • Committees
      • Committee Interest Form
    • NASBS Policy
    • Donate Now to the NASBS
    • Contact Us
  • Meetings
    • 2026 Annual Meeting
    • Abstracts
      • 2026 Call for Abstracts
      • NASBS Poster Archives
      • 2025 Abstract Awards
    • 2026 Recap
    • NASBS Summer Course
    • Meetings Archive
    • Other Skull Base Surgery Educational Events
  • Resources
    • Member Survey Application
    • NASBS Travel Scholarship Program
    • Research Grants
    • Fellowship Registry
    • The Rhoton Collection
    • Webinars
      • Research Committee Workshop Series
      • ARS/AHNS/NASBS Sinonasal Webinar
      • Surgeon’s Log
      • Advancing Scholarship Series
      • Trials During Turnover: Webinar Series
    • NASBS iCare Pathway Resources
    • Billing & Coding White Paper
  • Membership
    • Join NASBS
    • Membership Directory
    • Multidisciplinary Teams of Distinction
    • NASBS Mentorship Program
  • Fellowship Match
    • NASBS Neurosurgery Skull Base Fellowship Match Programs
    • NASBS Neurosurgery Skull Base Fellowship Match Application
  • Journal
  • Login/Logout

2026 Poster Presentations

2026 Poster Presentations

 

← Back to Previous Page

 

P243: BILATERAL SSCD AND HYPOALBUMINEMIA ARE LINKED TO DISTINCT POSTOPERATIVE OUTCOMES: 250 CASE SERIES
Lisa Liff; Mahlet Mekennon; Anubhav Chandla; Natalie Mahgerefteh; Quinton Gopen, MD; Isaac Yang, MD; UCLA DGSOM

Background: Superior semicircular canal dehiscence (SSCD) is an audiovestibular disorder due to a bone defect in the middle cranial fossa. Interestingly there are a certain subset of patients who present with bilateral SSCD. Given known associations between thyroid problems, albumin imbalance, bone integrity, and auditory dysfunction, we investigated whether there was a significant difference in bilateral SSCD among these patients and whether symptom resolution post-SSCD surgery differs.

Methods: A retrospective chart review was conducted for 250 cases treated with SSCD repair. Symptom resolution following middle cranial fossa craniotomy was evaluated. Fisher’s exact (p < .05) and one-tailed binomial tests assessed whether symptom improvement in patients with autoimmune or thyroid disorders exceeded chance (p > 0.5). Albumin status and bilateral SSCD relationship was assessed using a Welch’s two-sample t-test

Results: Of the 250 cases, 16 had an autoimmune disorder, 57 had a thyroid pathology, and 5 had both. Within the 182 cases with neither an autoimmune disorder nor a history of thyroid, there was significant improvement in autophony (p = .001), amplification (p = .001), hyperacusis (p = .001), and vertigo (p = .01) . However, those with an autoimmune disorder only showed resolution in autophony (p = .002). Those with a history of thyroid had improvement in amplification (p = .001), hyperacusis (p = .01), and autophony (p = .01). Additionally, bilateral SSCD patients had a significantly lower mean serum albumin level (5.03 ± 0.24; n = 28 (72%), p = 0.018). Patients with a thyroid problem had significantly lower mean serum albumin level (4.26 ± .36; p = .027). When stratified by albumin status, patients with low albumin demonstrated significant improvement only in hearing loss, dizziness, and disequilibrium imbalance (all p<.05), while no other symptoms improved.

Conclusion: Autoimmune comorbidities and albumin level may contribute to SSCD pathophysiology and rate of symptom resolution post-SSCD repair. Bilateral SSCD and thyroid pathology were both associated with lower serum albumin levels, and patients with hypoalbuminemia showed a restricted pattern of postoperative improvement limited to auditory and balance-related symptoms.

View Poster

 

← Back to Previous Page

Copyright © 2026 North American Skull Base Society · Managed by BSC Management, Inc · All Rights Reserved